New Drug's breast milk safety under microscope
NCT ID NCT06961747
First seen Apr 05, 2026 · Last updated Jun 23, 2026 · Updated 14 times
Summary
This study is testing how much of the drug zilucoplan gets into breast milk after daily injections. Fifteen healthy lactating women who have already decided to stop breastfeeding will provide milk samples over 24 hours. The goal is to estimate how much drug an infant might consume, helping to assess safety for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UP0137 1
RECRUITINGSalt Lake City, Utah, 84124, United States
-
UP0137 2
RECRUITINGSan Antonio, Texas, 78209, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
zilucoplan
What this could lead to
If successful, this study will help determine whether zilucoplan is safe for infants exposed through breast milk, guiding future use in breastfeeding mothers.
What could go wrong
This is a very small, early-phase study in healthy women, not patients. Results may not reflect real-world conditions or guarantee safety for all infants.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.